Literature DB >> 7945296

Genistein, an inhibitor of protein tyrosine kinase, is also a competitive antagonist for P1-purinergic (adenosine) receptor in FRTL-5 thyroid cells.

F Okajima1, M Akbar, M Abdul Majid, K Sho, H Tomura, Y Kondo.   

Abstract

Genistein, a potent inhibitor for protein tyrosine kinase, remarkably inhibited the stimulatory action of N6-(L-2-phenylisopropyl)adenosine (PIA), an A1-adenosine receptor agonist, on thyrotropin (TSH)-induced phospholipase C activation in FRTL-5 thyroid cells. This drug also suppressed both the A1-receptor-mediated inhibition of cAMP accumulation in the cells and binding of [3H]8-cyclopentyl-1,3-dipropylxanthine, a specific antagonist for A1-receptor, to the cell membranes in a competitive manner. Adenosine-induced cAMP accumulation through A2-receptor in pertussis toxin-treated cells was also competitively antagonized by genistein. We conclude that genistein is also a competitive antagonist for P1-purinergic receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945296     DOI: 10.1006/bbrc.1994.2353

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Thyrotropin regulates adenosine A(1) receptor expression in rat thyroid FRTL-5 cells.

Authors:  M Vainio; B B Fredholm; K Törnquist
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 2.  Interactions of flavones and other phytochemicals with adenosine receptors.

Authors:  Kenneth A Jacobson; Stefano Moro; John A Manthey; Patrick L West; Xiao-Duo Ji
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

Review 3.  Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development.

Authors:  Chrisna Matthee; Gisella Terre'Blanche; Lesetja J Legoabe; Helena D Janse van Rensburg
Journal:  Mol Divers       Date:  2021-06-27       Impact factor: 3.364

4.  Genistein-supplemented diet decreases malaria liver infection in mice and constitutes a potential prophylactic strategy.

Authors:  Margarida Cunha-Rodrigues; Sílvia Portugal; Miguel Prudêncio; Lígia A Gonçalves; Cristina Casalou; Dominik Buger; Robert Sauerwein; Werner Haas; Maria M Mota
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

5.  Adenosine Receptor Ligands: Coumarin-Chalcone Hybrids as Modulating Agents on the Activity of hARs.

Authors:  Saleta Vazquez-Rodriguez; Santiago Vilar; Sonja Kachler; Karl-Norbert Klotz; Eugenio Uriarte; Fernanda Borges; Maria João Matos
Journal:  Molecules       Date:  2020-09-19       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.